Literature DB >> 18545011

Contact lens-related microbial keratitis: recent outbreaks.

Avni Patel1, Kristin Hammersmith.   

Abstract

PURPOSE OF REVIEW: This paper reviews the literature generated on atypical contact lens-related infections and their relationship with particular contact lens solutions since 2005. RECENT
FINDINGS: Atypical soft contact lens-related infections are on the rise. Specifically, there has been an insurgence of Acanthamoeba keratitis and Fusarium keratitis. The rise in these infections was associated with Advanced Medical Optics Complete MoisturePlus (AMO, Santa Ana, California, USA) and ReNu with MoistureLoc (Bausch and Lomb, Rochester, New York, USA) respectively. Contact lens solutions in general are more effective against bacteria than fungal species or Acanthamoeba. Multipurpose solutions and no rub formulas may have diminished antimicrobial activity and are not as effective under real world conditions.
SUMMARY: There have been epidemic increases in Acanthamoeba and fungal keratitis associated with particular contact lens solutions. Further study of these atypical species is necessary. Greater emphasis should be placed upon efficacy of contact lens solutions rather than ease of use.

Entities:  

Mesh:

Year:  2008        PMID: 18545011     DOI: 10.1097/ICU.0b013e3283045e74

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  30 in total

Review 1.  Current state of in vivo confocal microscopy in management of microbial keratitis.

Authors:  Radhika L Kumar; Andrea Cruzat; Pedram Hamrah
Journal:  Semin Ophthalmol       Date:  2010 Sep-Nov       Impact factor: 1.975

Review 2.  Antimicrobial compounds in tears.

Authors:  Alison M McDermott
Journal:  Exp Eye Res       Date:  2013-07-20       Impact factor: 3.467

3.  [Therapy-resistant purulent keratoconjunctivitis].

Authors:  D Karimdadian; N Feltgen; H Hoerauf
Journal:  Ophthalmologe       Date:  2012-03       Impact factor: 1.059

4.  Acanthamoeba T4 genotype associated with keratitis infections in Tunisia.

Authors:  F Dendana; H Sellami; H Trabelsi; S Neji; F Cheikhrouhou; F Makni; A Ayadi
Journal:  Parasitol Res       Date:  2012-10-05       Impact factor: 2.289

5.  Cytotoxic effect of acriflavine against clinical isolates of Acanthamoeba spp.

Authors:  Zubeyda Akin Polat; Gulderen Karakus
Journal:  Parasitol Res       Date:  2012-10-10       Impact factor: 2.289

6.  TREM-2 promotes host resistance against Pseudomonas aeruginosa infection by suppressing corneal inflammation via a PI3K/Akt signaling pathway.

Authors:  Mingxia Sun; Min Zhu; Kang Chen; Xinxin Nie; Qiuchan Deng; Linda D Hazlett; Yongjian Wu; Meiyu Li; Minhao Wu; Xi Huang
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-05-17       Impact factor: 4.799

7.  A three-phase in-vitro system for studying Pseudomonas aeruginosa adhesion and biofilm formation upon hydrogel contact lenses.

Authors:  Claudia Rändler; Rutger Matthes; Andrew J McBain; Bernd Giese; Martin Fraunholz; Rabea Sietmann; Thomas Kohlmann; Nils-Olaf Hübner; Axel Kramer
Journal:  BMC Microbiol       Date:  2010-11-09       Impact factor: 3.605

8.  Flagellin-induced expression of CXCL10 mediates direct fungal killing and recruitment of NK cells to the cornea in response to Candida albicans infection.

Authors:  Xiaowei Liu; Nan Gao; Chen Dong; Li Zhou; Qing-Sheng Mi; Theodore J Standiford; Fu-Shin X Yu
Journal:  Eur J Immunol       Date:  2014-08-14       Impact factor: 5.532

9.  Failure of chemotherapy in the first reported cases of Acanthamoeba keratitis in Pakistan.

Authors:  Ruqaiyyah Siddiqui; Tanveer Chaudhry; Sahreena Lakhundi; Khabir Ahmad; Naveed Ahmed Khan
Journal:  Pathog Glob Health       Date:  2013-12-27       Impact factor: 2.894

10.  Protective role of murine β-defensins 3 and 4 and cathelin-related antimicrobial peptide in Fusarium solani keratitis.

Authors:  Satya Sree N Kolar; Hasna Baidouri; Samuel Hanlon; Alison M McDermott
Journal:  Infect Immun       Date:  2013-05-13       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.